CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline AENT Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher SSR Mining Q1 2026 Earnings EPS Surges Past Estimates by 318 as Stock Declines Immunovant Q1 2026 Earnings WiderThanExpected Loss as Pipeline Investment Continues CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances TLK Q4 2025 Earnings Significant EPS Miss Sends Shares Lower